Use of long‐acting cabotegravir and rilpivirine in people living with <scp>HIV</scp> : A prospective observational cohort study

20260 citationsJournal Article

Authors

CAB+RPV LA appears to be an effective, safe and durable option for a switch strategy.

Zero hunger

Published in: HIV Medicine

Field-Weighted Citation Impact: 0.00